Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days
Assia Chemical Industries Ltd. has 8 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 8 distinct examiners across 6 distinct art units, showing a broad distribution of prosecution activity within the technology area.
MAHLUM, JONATHAN DAVIS is the busiest examiner, with 1 pending matter. Because no examiner carries a larger recorded share, counsel may benefit from matter-specific preparation and separate review of the applicable art-unit practices.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (12%) |
| §112 only | 3 (38%) |
| Multi-statute (no §101) | 4 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MAHLUM, JONATHAN DAVIS | 1 | 50.0% | +23.3% |
| FETTEROLF, BRANDON J | 1 | 51.6% | +18.5% |
| REDWOOD, CHRISTOPHER EVAN | 1 | 0.0% | +0.0% |
| HERNANDEZ, JACKSON J | 1 | 50.7% | +39.2% |
| SHOWALTER, ALEXANDER KEITH | 1 | 55.4% | +27.3% |
| NOTTINGHAM, KYLE GREGORY | 1 | 61.7% | +31.9% |
| WELLS, LAUREN QUINLAN | 1 | 49.4% | +59.7% |
| RODRIGUEZ, RAYNA B | 1 | 33.6% | +19.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18856081 | SOLID STATE FORMS OF MAVACAMTEN AND PROCESS FOR PREPARATION THEREOF | REDWOOD, CHRISTOPHER EVAN | — |
| 18843819 | SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS | HERNANDEZ, JACKSON J | — |
| 18710701 | SOLID STATE FORM OF TAFAMIDIS | NOTTINGHAM, KYLE GREGORY | — |
| 18710688 | SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF | WELLS, LAUREN QUINLAN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18872457 | SOLID STATE FORMS OF PALTUSOTINE AND PROCESS FOR PREPARATION THEREOF | MAHLUM, JONATHAN DAVIS | — |
| 18858794 | SOLID STATE FORMS OF MIRDAMETINIB AND PROCESS FOR PREPARATION THEREOF | FETTEROLF, BRANDON J | — |
| 18843819 | SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS | HERNANDEZ, JACKSON J | — |
| 18837960 | CRYSTALLINE FORMS OF TRILACICLIB AND TRILACICLIB SALTS | SHOWALTER, ALEXANDER KEITH | — |
| 18710701 | SOLID STATE FORM OF TAFAMIDIS | NOTTINGHAM, KYLE GREGORY | — |
| 18710688 | SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF | WELLS, LAUREN QUINLAN | — |
| 18567414 | SOLID STATE FORMS OF 4-[[4-(4-CHLOROANILINO)FURO[2,3-d]PYRIDAZIN-7-yl]OXYMETHYL]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND SALT THEREOF | RODRIGUEZ, RAYNA B | — |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1627 | 1 |
| 1629 | 1 |
| 1621 | 1 |
| 1622 | 1 |
| 1628 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18872457 | SOLID STATE FORMS OF PALTUSOTINE AND PROCESS FOR PREPARATION THEREOF | MAHLUM, JONATHAN DAVIS | 1625 | §112 | Non-Final OA | — | Pending | Dec 06, 2024 |
| 18858794 | SOLID STATE FORMS OF MIRDAMETINIB AND PROCESS FOR PREPARATION THEREOF | FETTEROLF, BRANDON J | — | §103 | Non-Final OA | — | Pending | Oct 22, 2024 |
| 18856081 | SOLID STATE FORMS OF MAVACAMTEN AND PROCESS FOR PREPARATION THEREOF | REDWOOD, CHRISTOPHER EVAN | — | §102§103§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18843819 | SOLID STATE FORMS OF TOLEBRUTINIB AND OF TOLEBRUTINIB SALTS | HERNANDEZ, JACKSON J | 1627 | §103§112 | Non-Final OA | — | Pending | Sep 04, 2024 |
| 18837960 | CRYSTALLINE FORMS OF TRILACICLIB AND TRILACICLIB SALTS | SHOWALTER, ALEXANDER KEITH | 1629 | §112 | Non-Final OA | — | Pending | Aug 13, 2024 |
| 18710701 | SOLID STATE FORM OF TAFAMIDIS | NOTTINGHAM, KYLE GREGORY | 1621 | §102§103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18710688 | SOLID STATE FORMS OF LOTILANER AND PROCESS FOR PREPARATION THEREOF | WELLS, LAUREN QUINLAN | 1622 | §103§112 | Non-Final OA | — | Pending | May 16, 2024 |
| 18567414 | SOLID STATE FORMS OF 4-[[4-(4-CHLOROANILINO)FURO[2,3-d]PYRIDAZIN-7-yl]OXYMETHYL]-N-METHYLPYRIDINE-2-CARBOXAMIDE AND SALT THEREOF | RODRIGUEZ, RAYNA B | 1628 | §112 | Final Rejection | — | Pending | Dec 06, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAssia Chemical Industries Ltd. has 8 pending office actions as of October 2026, spread across 6 art units and 8 examiners.
Jonathan Davis Mahlum has the most, with 1 of Assia Chemical Industries Ltd.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
